STOCK TITAN

Harris Williams Strengthens European Presence With Appointment of Dr. Julian Feneley as Managing Director, Healthcare & Life Sciences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary

Harris Williams announces the appointment of Dr. Julian Feneley as Managing Director in the Healthcare & Life Sciences (HCLS) group in London. With nearly 30 years of experience in the healthcare sector, Dr. Feneley will enhance the firm's European operations, focusing on pharma services, medical devices, and healthcare provider segments. Bob Baltimore and John Neuner expressed confidence in Dr. Feneley's expertise, vital for navigating the dynamic healthcare landscape. His prior roles include leading healthcare investment banking at Macquarie Capital and JP Morgan.

Positive
  • Dr. Julian Feneley's extensive 30-year experience in healthcare will strengthen Harris Williams' European operations.
  • The addition is expected to enhance the firm's capabilities in addressing increasing client demand across Europe.
Negative
  • Concerns may arise regarding continuity and potential experience gaps with the leadership change.

Brings Three Decades of Industry Advisory and Operational Experience

RICHMOND, Va.--(BUSINESS WIRE)-- Harris Williams, a global investment bank specializing in M&A advisory services, today announced that Dr. Julian Feneley has joined the firm’s London office as Managing Director, Healthcare & Life Sciences (HCLS). Dr. Feneley brings close to 30 years of healthcare and life sciences industry experience to Harris Williams, and will lead HCLS’s European efforts, building on the firm’s expertise across the group’s key verticals, including pharma services, medical devices, and numerous healthcare provider segments.

“We are excited to welcome Julian to Harris Williams as we continue to expand our global platform,” said Bob Baltimore and John Neuner, co-heads of M&A at Harris Williams. “As a seasoned and trusted advisor and proven industry executive, Julian brings an extensive understanding of the healthcare landscape and universe of sponsors and corporates globally that is critical to navigating an increasingly active and dynamic sector. Moreover, Julian values our firm’s culture of collaboration and integrity, and we look forward to his many contributions as we further strengthen our ability to meet increasing client demand across Europe.”

“Harris Williams has an outstanding reputation of unlocking value for its clients, and I’m delighted to join its insightful and dedicated team at this exciting time in the firm’s growth,” said Dr. Feneley. “I look forward to collaborating with my new colleagues as the firm continues to build its global presence.”

Cheairs Porter and Geoff Smith, co-heads of Harris Williams’ Healthcare & Life Sciences Group, added, “The sustained, robust expansion of healthcare and life sciences globally demands the deep industry relationships, expertise, and execution capabilities that Julian brings to our growing European business. We believe our unrivalled sector knowledge and unwavering commitment to client service uniquely positions us to guide our corporate and financial sponsor clients as they seek to capitalize on attractive opportunities around the world.”

Dr. Feneley was most recently Managing Director and Head of Healthcare Europe at Macquarie Capital (investment banking division of Macquarie Group). Previous experience includes serving as Head of Healthcare Investment Banking Europe at Canaccord Genuity Inc. after leading healthcare investment banking in Europe at JP Morgan. He also served as CEO of BriteSmile Inc, a leading US dental technology company that served more than 7,000 dental practice clients worldwide. Dr. Feneley earned MBBS (medical) and B.Sc (science) degrees from the University of London (Guy’s Hospital).

Harris Williams’ HCLS Group is dedicated to understanding the complex industry dynamics and providing superior merger and acquisition advisory services to companies that operate within it. The HCLS Group has deep experience across a broad range of sectors, including healthcare providers, payors and payor services, outsourced pharmaceutical services, medical device supply chain, healthcare IT, and pharmacy.

For more information on Harris Williams’ HCLS Group, please visit: https://www.harriswilliams.com/industries/healthcare-and-life-sciences.

About Harris Williams

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

Media:

Julia Moore

media@harriswilliams.com

Nathaniel Garnick/Mark Semer/Kevin FitzGerald

Gasthalter & Co.

(212) 257-4170

HarrisWilliams@gasthalter.com

Source: Harris Williams

FAQ

Who is Dr. Julian Feneley and what role has he taken at Harris Williams?

Dr. Julian Feneley has joined Harris Williams as Managing Director for Healthcare & Life Sciences, bringing nearly 30 years of industry experience.

What is the expected impact of Dr. Feneley's appointment on Harris Williams?

Dr. Feneley's appointment is expected to enhance Harris Williams' expertise in the healthcare sector and meet growing client demands in Europe.

What previous positions did Dr. Feneley hold before joining Harris Williams?

Dr. Feneley was Managing Director and Head of Healthcare Europe at Macquarie Capital and previously led healthcare investment banking at JP Morgan.

What sectors will Dr. Feneley focus on at Harris Williams?

Dr. Feneley will focus on pharma services, medical devices, and healthcare provider segments within the firm's Healthcare & Life Sciences group.

PNC Financial Services Group

NYSE:PNC

PNC Rankings

PNC Latest News

PNC Stock Data

77.01B
395.16M
0.37%
85.6%
1.27%
Banks - Regional
National Commercial Banks
Link
United States of America
PITTSBURGH